Department of General Surgical Science, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma 371-8511, Japan.
J Med Invest. 2021;68(1.2):129-135. doi: 10.2152/jmi.68.129.
Background : With regard to the recurrence of esophageal cancer after surgery, the prognosis has improved with the progress of multimodal perioperative treatment. In this study, the recurrence pattern, treatment method, and prognosis of recurrent cases following esophageal cancer surgery were retrospectively examined. Materials and Methods : Three hundred seven patients with histologically proven squamous cell carcinoma, adenocarcinoma, and others were enrolled in the study. With respect to clinicopathologic factors and recurrence patterns, recurrence risk factors, recurrence period, treatment for recurrence, and prognosis were investigated.Results : Ninety two percent of all recurrent cases were observed within two years after radical esophagectomy. Locoregional recurrence, distant recurrence, and mixed recurrence were observed in 38 (35%), 56 (51%), and 16 (14%) cases, respectively. Patients with lymph node metastasis showed a significantly longer survival in comparison to those with metastasis to other organs (p = 0.0032). When analyzed using the treatment method, patients who underwent surgery (only surgery or additional postoperative chemotherapy) exhibited better survival in comparison to those who underwent other treatments. Discussion : Detailed and strict follow-up within two years are necessary in cases with deeper than muscular invasion, cases with extensive lymph node metastasis, or cases with lymphatic or vascular invasion. J. Med. Invest. 68 : 129-135, February, 2021.
随着多模态围手术期治疗的进展,食管癌手术后复发的预后得到改善。在本研究中,回顾性检查了食管癌手术后复发病例的复发模式、治疗方法和预后。
本研究纳入了 307 名经组织学证实为鳞状细胞癌、腺癌和其他类型的患者。根据临床病理因素和复发模式,研究了复发的危险因素、复发期、复发后的治疗和预后。
所有复发病例中有 92%在根治性食管切除术后两年内观察到。局部区域复发、远处复发和混合复发分别在 38(35%)、56(51%)和 16(14%)例中观察到。与转移至其他器官的患者相比,有淋巴结转移的患者生存时间明显更长(p=0.0032)。当按治疗方法进行分析时,接受手术(仅手术或术后辅助化疗)的患者的生存情况明显优于接受其他治疗的患者。
对于浸润深度超过肌层、广泛淋巴结转移、淋巴管或血管侵犯的病例,需要在两年内进行详细和严格的随访。
J. Med. Invest. 68 : 129-135, February, 2021.